Sacral nerve modulation for irritable bowel syndrome: A randomized, double-blinded, placebo-controlled crossover...

Area of Science:

• Gastroenterology
• Neurology

Background:

• Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder with many patients unresponsive to current treatments.
• Previous studies indicated sacral nerve modulation (SNM) may alleviate IBS symptoms.

Purpose of the Study:

• To evaluate the efficacy of SNM in treating IBS through a double-blind, randomized, placebo-controlled trial.
• To assess the impact of SNM on IBS-specific symptoms and quality of life.

Main Methods:

• A 6-week study involving patients with moderate to severe IBS (Gastrointestinal Symptom Rating Scale-IBS score ≥40).
• Patients underwent a 4-week randomized, double-blind, placebo-controlled crossover phase (subsensory stimulation vs. OFF), followed by 2 weeks of suprasensory stimulation.
• Symptom assessment utilized validated questionnaires and daily bowel diaries.

Main Results:

• SNM demonstrated a trend towards reducing overall IBS symptom scores (P=0.0572).
• Significant reductions were observed in pain (P=0.0188) and daily bowel movement frequency (P=0.0373) during stimulation.
• A median placebo effect of 14% was noted.

Conclusions:

• SNM appears to be a promising experimental treatment for IBS, particularly for pain and bowel movement irregularities.
• Larger, multicenter studies are required to validate these preliminary findings and establish SNM's role in IBS management.